CLINICAL ROLE -
EP. 1: Treatment Goals and Recommended Frontline Options for CLL
Watch
EP. 2: Key Considerations for Individualizing Therapy in CLL
EP. 3: Data on Limited-Duration Therapy in CLL with MRD Testing
EP. 4: Role of BTK Inhibitor Monotherapy in CLL Frontline Setting
EP. 5: New and Pipeline BTK Inhibitors in CLL at the Frontline
EP. 6: CAPTIVATE Study BTK Inhibitors With BCL2 Inhibitors in CLL
EP. 7: Venetoclax + Obinutuzumab: for Combination Therapy
EP. 8: Second-Line Therapy in CLL: RESONATE Trial Data
